Part B News | Inflation Reduction Act Caps Insulin Costs, Grants CMS Drug Negotiating Power

This week, Congress is expected to pass the Inflation Reduction Act of 2022, which includes numerous health-related provisions such as prescription drug inflation rebates; out-of-pocket caps for Medicare Part D; and drug price negotiation.

This week, CMS announced a record level of Marketplace enrollments, and the White House issued a memorandum on protecting access to reproductive healthcare services. 

This week, CMS announced the implementation of 200 Medicare physician residency slots in underserved communities and HHS released key dates for the Medicare Drug Price Negotiation Program.

Emily Shaw is quoted on the potential legal challenges to Medicare drug price negotiation enacted in the Inflation Reduction Act.

This week, CMS released the CY 2023 Payment Policies under PFS Proposed Rule and HRSA distributed over $142 million in Phase 4 PRF payments to over 150 providers.